Approval · Notice of Compliance 26147 · 2021
SYNALAR: Notice of Compliance 26147
Issued June 25, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26147
- Date
- June 25, 2021
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with additional adverse skin reactions and to update to 2020 PM format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNALAR | Not yet assigned | — |
Medicinal ingredients
- FLUOCINOLONE ACETONIDE 0.025 PER
- FLUOCINOLONE ACETONIDE 0.01 PER